Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsBiotechnology Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 1632627

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1632627

Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location (Point of Care, Self-Test), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 269 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Molecular Diagnostics Market Growth & Trends:

The global molecular diagnostics market size is estimated to reach USD 33.08 billion by 2030, expanding at a CAGR of 3.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth.

Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.

Companies are expanding their product portfolios with the acquisition of smaller companies. For instance, in March 2021, Hologic announced the acquisition of Diagenode-a molecular diagnostic company with a wide range of PCR instruments, facilitating the detection of over 30 bacteria-for USD 159 million. Similarly, in April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. at a price of USD 24.05 per share in cash, and it holds around 82.89% of total shares of GenMark Diagnostics. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, which can be utilized in developing tests for infectious diseases, including bloodstream infections.

Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the global molecular diagnostics market.

Molecular Diagnostics Market Report Highlights:

  • The reagents segment dominated the market and accounted for a share of 65.44% of the global revenue in 2024. It is expected to maintain its dominance throughout the forecast years owing to its wide application scope in research & clinical settings and increasing adoption of novel tests.
  • The polymerase chain reaction technology segment accounted for the largest revenue share in 2024. This is attributed to its use in detecting COVID-19 and other infectious diseases.
  • The infectious diseases segment accounted for the largest revenue share in 2024. The increased usage of molecular, particularly PCR tests, for diagnosing COVID-19 has increased the segment share significantly.
  • The central laboratories segment dominated the industry in 2024 owing to high procedure volumes for COVID testing and other healthcare indications in central laboratories.
  • North America dominated the market and accounted for a 40.95% share in 2024. This is attributed to the rising epidemiology of infectious as well as chronic diseases, thus, encouraging companies to introduce novel molecular diagnostic tests, thereby boosting market growth.
  • Asia Pacific is anticipated to exhibit significant growth from 2025 to 2030 owing to increased market penetration, initiatives of local market players to increase the adoption of novel diagnostic technologies, and high unmet market needs.
Show more
Product Code: 978-1-68038-086-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Molecular Diagnostics Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in geriatric population
      • 3.2.1.2. Introduction of technologically advanced products
      • 3.2.1.3. Increase in demand for point-of-care Testing
      • 3.2.1.4. Growing prevalence of target diseases
      • 3.2.1.5. Increasing external funding for R&D
      • 3.2.1.6. Outbreak of COVID-19
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Presence of ambiguous regulatory framework
      • 3.2.2.2. High prices of molecular diagnostics tests
  • 3.3. Molecular Diagnostics Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Molecular Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Molecular Diagnostics Market, by Product, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.4.1. Instruments
      • 4.4.1.1. Instruments market, 2018 - 2030 (USD Million)
    • 4.4.2. Reagents
      • 4.4.2.1. Reagents market, 2018 - 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Molecular Diagnostics Market: Segment Analysis, By Test Location, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Test Location Market Share Analysis, 2024 & 2030
  • 5.3. Global Molecular Diagnostics Market, by Test Location, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.4.1. Point of care
      • 5.4.1.1. Point of care market, 2018 - 2030 (USD Million)
    • 5.4.2. Self test or OTC
      • 5.4.2.1. Self test or OTC market, 2018 - 2030 (USD Million)
    • 5.4.3. Central laboratories
      • 5.4.3.1. Central laboratories market, 2018 - 2030 (USD Million)

Chapter 6. Molecular Diagnostics Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Technology Market Share Analysis, 2024 & 2030
  • 6.3. Global Molecular Diagnostics Market, by Technology, 2018 to 2030
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.4.1. PCR
      • 6.4.1.1. PCR market, 2018 - 2030 (USD Million)
      • 6.4.1.2. By procedure
        • 6.4.1.2.1. Nucleic acid extraction
          • 6.4.1.2.1.1. Nucleic acid extraction market, 2018 - 2030 (USD Million)
        • 6.4.1.2.2. Others
          • 6.4.1.2.2.1. Others market, 2018 - 2030 (USD Million)
      • 6.4.1.3. By type
        • 6.4.1.3.1. Multiplex
          • 6.4.1.3.1.1. Multiplex market, 2018 - 2030 (USD Million)
        • 6.4.1.3.2. Others
          • 6.4.1.3.2.1. Others market, 2018 - 2030 (USD Million)
      • 6.4.1.4. By product
        • 6.4.1.4.1. Instruments
          • 6.4.1.4.1.1. Instruments market, 2018 - 2030 (USD Million)
        • 6.4.1.4.2. Reagents
          • 6.4.1.4.2.1. Reagents market, 2018 - 2030 (USD Million)
        • 6.4.1.4.3. Others
          • 6.4.1.4.3.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.2. ISH
      • 6.4.2.1. ISH market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Instruments
        • 6.4.2.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.2.3. Reagents
        • 6.4.2.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.2.4. Others
        • 6.4.2.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.3. INAAT
      • 6.4.3.1. INAAT market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Instruments
        • 6.4.3.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.3.3. Reagents
        • 6.4.3.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.3.4. Others
        • 6.4.3.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.4. Chips and microarrays
      • 6.4.4.1. Chips and microarrays market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Instruments
        • 6.4.4.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.4.3. Reagents
        • 6.4.4.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.4.4. Others
        • 6.4.4.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.5. Mass spectrometry
      • 6.4.5.1. Mass spectrometry market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Instruments
        • 6.4.5.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.5.3. Reagents
        • 6.4.5.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.5.4. Others
        • 6.4.5.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.6. Sequencing
      • 6.4.6.1. Sequencing market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Instruments
        • 6.4.6.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.6.3. Reagents
        • 6.4.6.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.6.4. Others
        • 6.4.6.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.7. TMA
      • 6.4.7.1. TMA market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Instruments
        • 6.4.7.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.7.3. Reagents
        • 6.4.7.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.7.4. Others
        • 6.4.7.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.8. Others
      • 6.4.8.1. Others market, 2018 - 2030 (USD Million)
      • 6.4.8.2. Instruments
        • 6.4.8.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.8.3. Reagents
        • 6.4.8.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.8.4. Others
        • 6.4.8.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 7. Molecular Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. Application Market Share Analysis, 2024 & 2030
  • 7.3. Global Molecular Diagnostics Market, by Application,2018 to 2030
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.4.1. Oncology
      • 7.4.1.1. Oncology market, 2018 - 2030 (USD Million)
      • 7.4.1.2. Breast cancer
        • 7.4.1.2.1. Breast cancer market, 2018 - 2030 (USD Million)
      • 7.4.1.3. Prostate cancer
        • 7.4.1.3.1. Prostate cancer market, 2018 - 2030 (USD Million)
      • 7.4.1.4. Colorectal cancer
        • 7.4.1.4.1. Colorectal cancer market, 2018 - 2030 (USD Million)
      • 7.4.1.5. Cervical
        • 7.4.1.5.1. Cervical market, 2018 - 2030 (USD Million)
      • 7.4.1.6. Kidney
        • 7.4.1.6.1. Kidney market, 2018 - 2030 (USD Million)
      • 7.4.1.7. Liver
        • 7.4.1.7.1. Liver market, 2018 - 2030 (USD Million)
      • 7.4.1.8. Blood
        • 7.4.1.8.1. Blood market, 2018 - 2030 (USD Million)
      • 7.4.1.9. Lung
        • 7.4.1.9.1. Lung market, 2018 - 2030 (USD Million)
      • 7.4.1.10. Other
        • 7.4.1.10.1. Other market, 2018 - 2030 (USD Million)
    • 7.4.2. Pharmacogenomics
      • 7.4.2.1. Pharmacogenomics market, 2018 - 2030 (USD Million)
    • 7.4.3. Infectious disease
      • 7.4.3.1. Infectious disease market, 2018 - 2030 (USD Million)
      • 7.4.3.2. MRSA
        • 7.4.3.2.1. MRSA market, 2018 - 2030 (USD Million)
      • 7.4.3.3. Clostridium difficile
        • 7.4.3.3.1. Clostridium difficile market, 2018 - 2030 (USD Million)
      • 7.4.3.4. Vancomycin-resistant enterococci
        • 7.4.3.4.1. Vancomycin-resistant enterococci market, 2018 - 2030 (USD Million)
      • 7.4.3.5. Carbapenem-resistant bacteria testing
        • 7.4.3.5.1. Carbapenem-resistant bacteria testing market, 2018 - 2030 (USD Million)
      • 7.4.3.6. Flu
        • 7.4.3.6.1. Flu market, 2018 - 2030 (USD Million)
      • 7.4.3.7. Respiratory syncytial virus (RSV)
        • 7.4.3.7.1. Respiratory syncytial virus (RSV) market, 2018 - 2030 (USD Million)
      • 7.4.3.8. Candida
        • 7.4.3.8.1. Candida market, 2018 - 2030 (USD Million)
      • 7.4.3.9. Tuberculosis and drug-resistant TB
        • 7.4.3.9.1. Tuberculosis and drug-resistant TB market, 2018 - 2030 (USD Million)
      • 7.4.3.10. Meningitis
        • 7.4.3.10.1. Meningitis market, 2018 - 2030 (USD Million)
      • 7.4.3.11. Gastro-intestinal panel testing
        • 7.4.3.11.1. Gastro-intestinal panel testing market, 2018 - 2030 (USD Million)
      • 7.4.3.12. Chlamydia
        • 7.4.3.12.1. Chlamydia market, 2018 - 2030 (USD Million)
      • 7.4.3.13. Gonorrhea
        • 7.4.3.13.1. Gonorrhea market, 2018 - 2030 (USD Million)
      • 7.4.3.14. HIV
        • 7.4.3.14.1. HIV market, 2018 - 2030 (USD Million)
      • 7.4.3.15. Hepatitis C
        • 7.4.3.15.1. Hepatitis C market, 2018 - 2030 (USD Million)
      • 7.4.3.16. Hepatitis B
        • 7.4.3.16.1. Hepatitis B market, 2018 - 2030 (USD Million)
      • 7.4.3.17. Other infectious diseases
        • 7.4.3.17.1. Other infectious diseases market, 2018 - 2030 (USD Million)
    • 7.4.4. Genetic testing
      • 7.4.4.1. Genetic testing market, 2018 - 2030 (USD Million)
      • 7.4.4.2. Newborn screening
        • 7.4.4.2.1. Newborn screening market, 2018 - 2030 (USD Million)
      • 7.4.4.3. Predictive and presymptomatic testing
        • 7.4.4.3.1. Predictive and presymptomatic testing market, 2018 - 2030 (USD Million)
      • 7.4.4.4. Others
        • 7.4.4.4.1. Others market, 2018 - 2030 (USD Million)
    • 7.4.5. Neurological disease
      • 7.4.5.1. Neurological disease market, 2018 - 2030 (USD Million)
    • 7.4.6. Cardiovascular disease
      • 7.4.6.1. Cardiovascular disease market, 2018 - 2030 (USD Million)
    • 7.4.7. Microbiology
      • 7.4.7.1. Microbiology market, 2018 - 2030 (USD Million)
    • 7.4.8. Others
      • 7.4.8.1. Others market, 2018 - 2030 (USD Million)

Chapter 8. Molecular Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Spain
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.6. Belgium
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Belgium market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.7. Switzerland
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Switzerland market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.8. Netherlands
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Netherlands market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.9. Poland
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement structure
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Poland market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.10. Austria
      • 8.4.10.1. Key country dynamics
      • 8.4.10.2. Regulatory framework/ reimbursement structure
      • 8.4.10.3. Competitive scenario
      • 8.4.10.4. Austria market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.11. Denmark
      • 8.4.11.1. Key country dynamics
      • 8.4.11.2. Regulatory framework/ reimbursement structure
      • 8.4.11.3. Competitive scenario
      • 8.4.11.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.12. Sweden
      • 8.4.12.1. Key country dynamics
      • 8.4.12.2. Regulatory framework/ reimbursement structure
      • 8.4.12.3. Competitive scenario
      • 8.4.12.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.13. Turkey
      • 8.4.13.1. Key country dynamics
      • 8.4.13.2. Regulatory framework/ reimbursement structure
      • 8.4.13.3. Competitive scenario
      • 8.4.13.4. Turkey market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.14. Norway
      • 8.4.14.1. Key country dynamics
      • 8.4.14.2. Regulatory framework/ reimbursement structure
      • 8.4.14.3. Competitive scenario
      • 8.4.14.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. China
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.6. Sri Lanka
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Sri Lanka market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.7. Malaysia
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Malaysia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.8. Vietnam
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Vietnam market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.9. Singapore
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory framework/ reimbursement structure
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Singapore market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.2. Colombia
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Colombia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.3. Chile
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Chile market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.4. Peru
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Peru market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.5. Argentina
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.3. Jordan
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Jordan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.5. Qatar
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Qatar market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.6. Egypt
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Egypt market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.7. Kuwait
      • 8.7.7.1. Key country dynamics
      • 8.7.7.2. Regulatory framework/ reimbursement structure
      • 8.7.7.3. Competitive scenario
      • 8.7.7.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Recent Developments & Impact Analysis by Key Market Participants
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Key Company Profiles
    • 9.4.1. BD
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. BIOMERIEUX
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Bio-Rad Laboratories, Inc.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Abbott
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Agilent Technologies, Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Danaher
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Hologic Inc. (Gen Probe)
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Illumina, Inc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Grifols
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. QIAGEN
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. F. Hoffmann-La Roche, Ltd.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Siemens Healthineers AG
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Sysmex Corporatio
Show more
Product Code: 978-1-68038-086-6

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 6 North America molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 7 North America molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. molecular diagnostics, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. molecular diagnostics, by test location, 2018 - 2030 (USD Million)
  • Table 10 U.S. molecular diagnostics, by technology, 2018 - 2030 (USD Million)
  • Table 11 U.S. molecular diagnostics, by application, 2018 - 2030 (USD Million)
  • Table 12 Canada molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 14 Canada molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Canada molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 16 Mexico molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 18 Mexico molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Mexico molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 23 Europe molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Europe molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 27 UK molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 28 UK molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 31 Germany molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Germany molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33 France molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 France molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 35 France molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 36 France molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Spain molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 39 Spain molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Spain molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 41 Italy molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 43 Italy molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Italy molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 45 Belgium molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Belgium molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 47 Belgium molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Belgium molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 49 Switzerland molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Switzerland molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 51 Switzerland molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Switzerland molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 53 Netherlands molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Netherlands molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 55 Netherlands molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Netherlands molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 57 Poland molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Poland molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 59 Poland molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Poland molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Austria molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Austria molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 63 Austria molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Austria molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Denmark molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 66 Denmark molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 67 Denmark molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Denmark molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Sweden molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 70 Sweden molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 71 Sweden molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Sweden molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 73 Turkey molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 74 Turkey molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 75 Turkey molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Turkey molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 Norway molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 78 Norway molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 79 Norway molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Norway molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 82 Asia Pacific molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 Asia Pacific molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 84 Asia Pacific molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 85 Asia Pacific molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 86 Japan molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Japan molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 88 Japan molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 89 Japan molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 90 China molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 91 China molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 92 China molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 93 China molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 94 India molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 95 India molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 96 India molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 97 India molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Australia molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 99 Australia molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 100 Australia molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Australia molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 New Zealand molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 103 New Zealand molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 104 New Zealand molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 105 New Zealand molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 106 Sri Lanka molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 107 Sri Lanka molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 108 Sri Lanka molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Sri Lanka molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 110 Malaysia molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 111 Malaysia molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 112 Malaysia molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 113 Malaysia molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 114 Thailand molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 115 Thailand molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 116 Thailand molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 117 Thailand molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 118 Vietnam molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 119 Vietnam molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 120 Vietnam molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 121 Vietnam molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 122 Singapore molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 123 Singapore molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 124 Singapore molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 125 Singapore molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 126 Latin America molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 127 Latin America molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 128 Latin America molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 129 Latin America molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 130 Latin America molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 131 Brazil molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 132 Brazil molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 133 Brazil molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 134 Brazil molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 135 Colombia molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 136 Colombia molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 137 Colombia molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 138 Colombia molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 139 Chile molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 140 Chile molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 141 Chile molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 142 Chile molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 143 Peru molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 144 Peru molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 145 Peru molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 146 Peru molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 147 Argentina molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 148 Argentina molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 149 Argentina molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 150 Argentina molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 151 MEA molecular diagnostics market, by country 2018 - 2030 (USD Million)
  • Table 152 MEA molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 153 MEA molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 154 MEA molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 155 MEA molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 156 South Africa molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 157 South Africa molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 158 South Africa molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 159 South Africa molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 160 Saudi Arabia molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 161 Saudi Arabia molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 162 Saudi Arabia molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 163 Saudi Arabia molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 164 Jordan molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 165 Jordan molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 166 Jordan molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 167 Jordan molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 168 UAE molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 169 UAE molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 170 UAE molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 171 UAE molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 172 Qatar molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 173 Qatar molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 174 Qatar molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 175 Qatar molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 176 Kuwait molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 177 Kuwait molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 178 Kuwait molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 179 Kuwait molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 180 Egypt molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 181 Egypt molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 182 Egypt molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 183 Egypt molecular diagnostics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Molecular diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Product and test location segment snapshot
  • Fig. 11 Technology segment snapshot
  • Fig. 12 Application segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Molecular diagnostics market value, 2024 (USD Billion)
  • Fig. 15 Market dynamics
  • Fig. 16 Global number of people aged over 60 years or over (thousands) in 2024
  • Fig. 17 Global estimated cancer incidence in different elderly age groups, 2022 (Million)
  • Fig. 18 General trend shifts from laboratory to point-of-care
  • Fig. 19 Incidence of cancer in North America, 2022-2050
  • Fig. 20 Incidence of cancer in Europe, 2022-2050
  • Fig. 21 Incidence of cancer in Asia Pacific, 2022-2050
  • Fig. 22 Incidence of cancer in Latin America, 2022-2050
  • Fig. 23 Incidence of cancer in Africa, 2022-2050
  • Fig. 24 Incidence of cancer in Oceania, 2022-2050
  • Fig. 25 Sources of healthcare financing according to country income, 2020 (%)
  • Fig. 26 Porter's five forces analysis
  • Fig. 27 PESTLE analysis
  • Fig. 28 Molecular diagnostics market: Product outlook and key takeaways
  • Fig. 29 Molecular diagnostics market: Product movement analysis
  • Fig. 30 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Molecular diagnostics market: Technology outlook and key takeaways
  • Fig. 34 Molecular diagnostics market: Technology movement analysis
  • Fig. 35 PCR market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Multiplex PCR market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Other PCR market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Nucleic acid extraction market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 In situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 INAAT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Transcription mediated amplification (TMA) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Molecular diagnostics market: Application outlook and key takeaways
  • Fig. 72 Molecular diagnostics market: Application movement analysis
  • Fig. 73 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Cervical cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Kidney cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Liver cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Blood cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Other cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Pharmacogenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Methicillin-resistant staphylococcus aureus (MRSA) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Vancomycin-resistant enterococci (VRE) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Carbapenem-resistant bacteria market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Flu market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Respiratory syncytial virus (RSV) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Candida market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Tuberculosis and drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Meningitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Gastrointestinal panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 HIV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Other infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 Genetic testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Newborn screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Predictive and presymptomatic testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Other genetic testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Neurological disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 Cardiovascular disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 Molecular diagnostics market: Test location outlook and key takeaways
  • Fig. 110 Molecular diagnostics market: Test location movement analysis
  • Fig. 111 Point of care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Self-test or over-the-counter market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 Central laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 114 Molecular diagnostics market revenue, by region, 2024 & 2030 (USD Million)
  • Fig. 115 Regional marketplace: Key takeaways
  • Fig. 116 Regional marketplace: Key takeaways
  • Fig. 117 North America molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 118 Key country dynamics
  • Fig. 119 Estimated cancer incidence in U.S., 2024 - 2030
  • Fig. 120 U.S. molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Key country dynamics
  • Fig. 122 Estimated cancer incidence in Canada, 2024 - 2030
  • Fig. 123 Canada molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 124 Key country dynamics
  • Fig. 125 Estimated cancer incidence in Mexico, 2024 - 2030
  • Fig. 126 Mexico molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 127 Europe molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 128 Key country dynamics
  • Fig. 129 Estimated cancer incidence in UK, 2024 - 2030
  • Fig. 130 UK molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 131 Key country dynamics
  • Fig. 132 Estimated cancer incidence in Germany, 2024 - 2030
  • Fig. 133 Germany molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 134 Key country dynamics
  • Fig. 135 Estimated cancer incidence in France, 2024 - 2030
  • Fig. 136 France molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 137 Key country dynamics
  • Fig. 138 Estimated cancer incidence in Spain, 2024 - 2030
  • Fig. 139 Spain molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 140 Key country dynamics
  • Fig. 141 Estimated cancer incidence in Italy, 2024 - 2030
  • Fig. 142 Italy molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 143 Key country dynamics
  • Fig. 144 Estimated cancer incidence in Denmark, 2024 - 2030
  • Fig. 145 Denmark molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 146 Key country dynamics
  • Fig. 147 Sweden molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 148 Key country dynamics
  • Fig. 149 Norway molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 150 Key country dynamics
  • Fig. 151 Belgium molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 152 Key country dynamics
  • Fig. 153 Switzerland molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 154 Key country dynamics
  • Fig. 155 Netherlands molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 156 Key country dynamics
  • Fig. 157 Poland molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 158 Key country dynamics
  • Fig. 159 Austria molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 160 Key country dynamics
  • Fig. 161 Turkey molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 162 Rest of Europe molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 163 Asia Pacific molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 164 Key country dynamics
  • Fig. 165 Japan molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 166 Key country dynamics
  • Fig. 167 China molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 168 Key country dynamics
  • Fig. 169 India molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 170 Key country dynamics
  • Fig. 171 Australia molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 172 Key country dynamics
  • Fig. 173 Thailand molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 174 Key country dynamics
  • Fig. 175 New Zealand molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 176 Key country dynamics
  • Fig. 177 Sri Lanka molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 178 Key country dynamics
  • Fig. 179 Malaysia molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 180 Key country dynamics
  • Fig. 181 Vietnam molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 182 Key country dynamics
  • Fig. 183 Singapore molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 184 Rest of Asia Pacific molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 185 Latin America molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 186 Key country dynamics
  • Fig. 187 Brazil molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 188 Key country dynamics
  • Fig. 189 Argentina molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 190 Key country dynamics
  • Fig. 191 Colombia molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 192 Key country dynamics
  • Fig. 193 Chile molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 194 Key country dynamics
  • Fig. 195 Peru molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 196 Rest of Latin America molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 197 MEA molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 198 Key country dynamics
  • Fig. 199 Estimated cancer incidence in South Africa, 2024 - 2030
  • Fig. 200 South Africa molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 201 Key country dynamics
  • Fig. 202 Estimated cancer incidence in Saudi Arabia, 2024 - 2030
  • Fig. 203 Saudi Arabia molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 204 Key country dynamics
  • Fig. 205 Estimated new cancer cases in UAE, 2024 - 2030
  • Fig. 206 UAE molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 207 Key country dynamics
  • Fig. 208 Kuwait molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 209 Key country dynamics
  • Fig. 210 Jordan molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 211 Key country dynamics
  • Fig. 212 Qatar molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 213 Key country dynamics
  • Fig. 214 Egypt molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 215 Rest of MEA molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 216 Key company categorization
  • Fig. 217 Global company market share analysis for molecular diagnostics, 2024
  • Fig. 218 North America company market share analysis for molecular diagnostics, 2024
  • Fig. 219 Europe company market share analysis for molecular diagnostics, 2024
  • Fig. 220 Asia Pacific company market share analysis for molecular diagnostics, 2024
  • Fig. 221 Latin America company market share analysis for molecular diagnostics, 2024
  • Fig. 222 MEA company market share analysis for molecular diagnostics, 2024
  • Fig. 223 Strategy mapping
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!